BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 68824)

  • 1. Analysis of prostatic fluid in prostatic disease.
    Grayhack JT; Wendel EF; Lee C; Oliver L
    Cancer Treat Rep; 1977; 61(2):205-10. PubMed ID: 68824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
    Sharief FS; Mohler JL; Sharief Y; Li SS
    Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histochemical characteristics of the prostate gland under normal conditions, in nodular hyperplasia and cancer].
    Bialik VV
    Arkh Patol; 1973; 35(12):12-8. PubMed ID: 4130950
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of serum lactate dehydrogenase, phosphohexose isomerase, aldolase and hexokinase in prostatic carcinoma.
    Yeshowardhana
    Indian J Physiol Pharmacol; 1985; 29(1):33-8. PubMed ID: 2414222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactate dehydrogenase isoenzymes in benign and malignant prostatic tissues.
    Mazzuca A; Lalanne GM
    Boll Soc Ital Biol Sper; 1980 Apr; 56(7):690-2. PubMed ID: 6160867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary report on the effect of medroxyprogesterone acetate on human prostate LDH-isoenzymes.
    Rutten J; van Sande M; Van Camp K
    Acta Urol Belg; 1977 Jan; 45(1):28-30. PubMed ID: 67788
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary report on the effect of gestonorone capronate on human prostate LDH-isoenzymes.
    Govaerts J; van Sande M; Van Camp K
    Acta Urol Belg; 1978; 46(4):389-92. PubMed ID: 83788
    [No Abstract]   [Full Text] [Related]  

  • 8. Lactic dehydrogenase isozymes in benign and malignant prostatic tissues.
    Srinivasan V; Keil E; Villalba R; Baron T; Clark SS
    Invest Urol; 1973 Nov; 11(3):244-7. PubMed ID: 4127178
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
    Miki M
    Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in serum lactate dehydrogenase activity and its isoenzyme pattern after massage of the prostate. Value in differentiating carcinoma from benign hyperplasia of the prostate.
    Ishibe T
    Invest Urol; 1971 Sep; 9(2):104-8. PubMed ID: 5120368
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical profiles of prostatic fluid from normal and diseased prostate glands.
    Grayhack JT; Lee C; Oliver L; Schaeffer AJ; Wendel EF
    Prostate; 1980; 1(2):227-37. PubMed ID: 15619922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Zinc levels in prostatic fluid of patients with prostate pathologies].
    Gómez Y; Arocha F; Espinoza F; Fernández D; Vásquez A; Granadillo V
    Invest Clin; 2007 Sep; 48(3):287-94. PubMed ID: 17853788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation and measurement of plasma prostatic acid phosphatase by solid phase enzyme immunoassay].
    Okabe H; Noma A; Nakauchi K; Mori M
    Rinsho Byori; 1986 Jul; 34(7):805-10. PubMed ID: 2428995
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum prostatic acid phosphatase determination in prostatic diseases: a critical comparison of an enzymatic and a radioimmunologic assay.
    Van Cangh PJ; Opsomer R; De Nayer P
    J Urol; 1982 Dec; 128(6):1212-5. PubMed ID: 6185698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enzymological study of prostatic cancer. II. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase activity and lactic dehydrogenase isoenzymes in prostatic cancer, with special reference to relation with stage and histological malignancy].
    Ishibe T; Nihira H; Mori K
    Hinyokika Kiyo; 1969 Apr; 15(4):254-65. PubMed ID: 5817349
    [No Abstract]   [Full Text] [Related]  

  • 16. Pre-analytical and biological variability of prostatic acid phosphatase and prostate-specific antigen in serum from patients with prostatic pathology.
    Panteghini M; Pagani F; Bonora R
    Eur J Clin Chem Clin Biochem; 1992 Mar; 30(3):135-9. PubMed ID: 1376155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of prostatic fluid in prostatic pathology.
    Grayhack JT; Lee C
    Prog Clin Biol Res; 1981; 75A():231-46. PubMed ID: 6175976
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate-specific acid phosphatase in Nigerian patients with prostate carcinoma.
    Bolarin DM; Badejo OA
    East Afr Med J; 1985 May; 62(5):332-7. PubMed ID: 2412782
    [No Abstract]   [Full Text] [Related]  

  • 19. [Citrate and acid phosphatase in the ejaculate in prostatic carcinoma and adenoma].
    Korth K; Wetterauer W; Wetterauer U; Heite HJ
    Hautarzt; 1978 Sep; 29(9):487-9. PubMed ID: 81063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diurnal variation of the elevated acid phosphatase activity in cases of prostate carcinoma (author's transl)].
    Wisser H; Knoll E; Schmid G
    J Clin Chem Clin Biochem; 1980 May; 18(5):297-301. PubMed ID: 7191887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.